Chromocell Therapeutics Corporation (CHRO)
Largest Insider Buys in Sector
CHRO Stock Price History Chart
CHRO Stock Performance
About Chromocell Therapeutics Corporation
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New …
Insider Activity of Chromocell Therapeutics Corporation
Over the last 12 months, insiders at Chromocell Therapeutics Corporation have bought $25,824 and sold $0 worth of Chromocell Therapeutics Corporation stock.
On average, over the past 5 years, insiders at Chromocell Therapeutics Corporation have bought $25,824 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Francis Knuettel II (CEO, Pres., CFO, Treas & Secty) — $31,998. Malamut Richard (director) — $9,825.
The last purchase of 3,500 shares for transaction amount of $3,395 was made by Francis Knuettel II (CEO, Pres., CFO, Treas & Secty) on 2024‑09‑13.
List of Insider Buy and Sell Transactions, Chromocell Therapeutics Corporation
| 2024-09-13 | CEO, Pres., CFO, Treas & Secty | 3,500 0.0922% | $0.97 | $3,395 | -29.77% | |||
| 2024-09-12 | CEO, Pres., CFO, Treas & Secty | 1,700 0.0448% | $0.97 | $1,649 | -33.65% | |||
| 2024-09-12 | director | 10,400 0.2668% | $0.94 | $9,825 | -33.65% | |||
| 2024-09-11 | CEO, Pres., CFO, Treas & Secty | 5,500 0.1404% | $0.94 | $5,170 | -32.31% | |||
| 2024-09-10 | CEO, Pres., CFO, Treas & Secty | 6,500 0.1571% | $0.89 | $5,785 | -29.34% |